Back to Search
Start Over
In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video).
- Source :
-
Gastrointestinal endoscopy [Gastrointest Endosc] 2014 Feb; Vol. 79 (2), pp. 211-21. Date of Electronic Publication: 2013 Nov 09. - Publication Year :
- 2014
-
Abstract
- Background: Confocal laser endomicroscopy (CLE) enables in vivo microscopic imaging of the GI tract mucosa. However, there are limited data on endoscope-based CLE (eCLE) for imaging Barrett's esophagus (BE).<br />Objective: To compare high-definition white-light endoscopy (HDWLE) alone with random biopsy (RB) and HDWLE + eCLE and targeted biopsy (TB) for diagnosis of BE neoplasia.<br />Design: Multicenter, randomized, controlled trial.<br />Setting: Academic medical centers.<br />Patients: Adult patients with BE undergoing routine surveillance or referred for early neoplasia.<br />Intervention: Patients were randomized to HDWLE + RB (group 1) or HDWLE + eCLE + TB (group 2). Real-time diagnoses and management plans were recorded after HDWLE in both groups and after eCLE in group 2. Blinded expert pathology diagnosis was the reference standard.<br />Main Outcome Measurements: Diagnostic yield, performance characteristics, clinical impact.<br />Results: A total of 192 patients with BE were studied. HDWLE + eCLE + TB led to a lower number of mucosal biopsies and higher diagnostic yield for neoplasia (34% vs 7%; P < .0001), compared with HDWLE + RB but with comparable accuracy. HDWLE + eCLE + TB tripled the diagnostic yield for neoplasia (22% vs 6%; P = .002) and would have obviated the need for any biopsy in 65% of patients. The addition of eCLE to HDWLE increased the sensitivity for neoplasia detection to 96% from 40% (P < .0001) without significant reduction in specificity. In vivo CLE changed the treatment plan in 36% of patients.<br />Limitations: Tertiary-care referral centers and expert endoscopists limit generalizability.<br />Conclusion: Real-time eCLE and TB after HDWLE can improve the diagnostic yield and accuracy for neoplasia and significantly impact in vivo decision making by altering the diagnosis and guiding therapy. (<br />Clinical Trial Registration Number: NCT01124214.).<br /> (Copyright © 2014 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.)
- Subjects :
- Adult
Aged
Aged, 80 and over
Barrett Esophagus complications
Biopsy
Esophageal Neoplasms etiology
Female
Follow-Up Studies
Humans
Male
Middle Aged
Prospective Studies
Reproducibility of Results
Single-Blind Method
Barrett Esophagus pathology
Esophageal Neoplasms diagnosis
Esophagoscopy methods
Esophagus pathology
Image Enhancement methods
Microscopy, Confocal
Subjects
Details
- Language :
- English
- ISSN :
- 1097-6779
- Volume :
- 79
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Gastrointestinal endoscopy
- Publication Type :
- Academic Journal
- Accession number :
- 24219822
- Full Text :
- https://doi.org/10.1016/j.gie.2013.09.020